RxSight, Inc. Reports First Quarter 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
RxSight Inc. (RXST) PT Raised to $75 at Stifel
May 7, 2024 6:04 AM EDTStifel analyst Tom Stephan raised the price target on RxSight Inc. (NASDAQ: RXST) to $75.00 (from $68.00) while maintaining a Buy rating.
The analyst comments "RXSTs 1Q24 results confirmed (and then some) why it has been viewed as one of the best 2024 momentum stories... More
RxSight Inc. (RXST) PT Raised to $68 at Wells Fargo
May 7, 2024 5:53 AM EDTWells Fargo analyst Lawrence Biegelsen raised the price target on RxSight Inc. (NASDAQ: RXST) to $68.00 (from $61.00) while maintaining a Overweight rating.
The analyst comments "We raise our 2024 EPS estimate from -$1.02 to -$0.86. Our price target increases to $68 (from $61) based on 13x (from 11x... More
RxSight Inc. (RXST) PT Raised to $72 at BTIG
May 7, 2024 5:19 AM EDTBTIG analyst Ryan Zimmerman raised the price target on RxSight Inc. (NASDAQ: RXST) to $72.00 (from $61.00) while maintaining a Buy rating.
The analyst comments "We reiterate our Buy and raise our PT to $72 PT (from $61) following 1Q24 results. RXST delivered a strong start to FY24 with 1Q24 revenue of $29.5M (69% Y/Y) and adj. LPS of $(0.25)... More
